Valuation: BioGaia AB

Market Cap 11.79B 1.22B 1.07B 986M 911M 1.73B 117B 1.76B 4.63B 57.44B 4.59B 4.49B 197B P/E 2026 *
28.8x
P/E 2027 * 23.9x
Enterprise Value 11.09B 1.15B 1.01B 928M 857M 1.63B 110B 1.65B 4.36B 54.06B 4.32B 4.23B 186B EV / Sales 2026 *
6.62x
EV / Sales 2027 * 5.91x
Free-Float
80.82%
Yield 2026 *
3.61%
Yield 2027 * 3.86%
1 day-2.35%
1 week-2.92%
Current month-0.34%
1 month-6.80%
3 months-2.92%
6 months+3.56%
Current year+9.70%
1 week 116.5
Extreme 116.5
121.5
1 month 114.5
Extreme 114.5
126.3
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 44.8
Extreme 44.8
139.7
Manager TitleAgeSince
Chief Executive Officer 60 2023-09-29
Director of Finance/CFO 59 2019-11-04
Chief Operating Officer 49 2020-12-31
Director TitleAgeSince
Chairman 77 2002-12-31
Chairman 76 2018-04-24
Director/Board Member 70 2023-05-04
Date Insider Type Main position Quantity % Market Cap.
02-12Buy

Director

582 0.0006%
12-29Buy

General Counsel

390 0.0004%
12-04Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
-2.35%-2.92%+8.37%-1.27% 1.25B
-0.51%+1.57%+18.72%-5.52% 67.96B
-5.16%-8.63%+37.37%+202.27% 54.4B
-2.10%+0.89%-49.30%-53.47% 41.74B
+5.28%+39.50%+39.50%+39.50% 40.63B
-10.83%-14.41%+99.15%-44.54% 30.38B
+0.12%-7.85%+47.16%-29.27% 29.37B
-1.53%-0.13%+65.92%+88.58% 23.68B
+3.88%+2.16%+11.78%+201.51% 19.15B
-4.75%+11.27%+85.63%+394.76% 17.68B
Average -1.80%-0.62%+36.43%+79.25% 32.62B
Weighted average by Cap. -1.73%-1.33%+32.37%+63.52%

Financials

2026 *2027 *
Net sales 1.68B 174M 152M 140M 129M 246M 16.57B 250M 658M 8.16B 652M 638M 28.07B 1.87B 194M 170M 157M 145M 274M 18.51B 279M 735M 9.12B 729M 713M 31.35B
Net income 410M 42.53M 37.2M 34.31M 31.69M 60.14M 4.06B 61.15M 161M 2B 160M 156M 6.87B 492M 51.04M 44.64M 41.18M 38.03M 72.16M 4.87B 73.38M 193M 2.4B 192M 187M 8.24B
Net Debt -694M -71.99M -62.97M -58.08M -53.65M -102M -6.87B -104M -273M -3.38B -270M -264M -11.63B -721M -74.79M -65.42M -60.34M -55.73M -106M -7.13B -108M -283M -3.51B -281M -275M -12.08B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
243
Date Price Change Volume
26-07-10 SEK 116.50 -2.35% 58,042
26-07-09 SEK 119.30 +0.93% 53,171
26-07-08 SEK 118.20 -0.25% 166,101
26-07-07 SEK 118.50 -0.50% 120,908
26-07-06 SEK 119.10 -0.75% 86,496
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
116.50SEK
Average target price
165.00SEK
Spread / Average Target
+41.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock